DFUs showed a high burden of carbapenemase-producing Gram-negative bacilli, driven mainly by blaKPC and blaNDM, and poor glycemic control was strongly associated with these resistant infections, positioning glycemic control as a modifiable driver of antimicrobial resistance in DFUs.
Key Findings
Results
Among 150 patients with infected diabetic foot ulcers, more than half had high-grade ulcers and the cohort was male-predominant.
Mean patient age was 56.4 ± 9.8 years.
Male predominance was 61.3%.
High-grade ulcers (Wagner III-V) were present in 54.7% of patients.
Design was cross-sectional, with isolates from deep tissue biopsies and other specimens.
Results
Klebsiella pneumoniae was the most common Gram-negative isolate in DFU infections.
K. pneumoniae accounted for 60.0% of isolates.
Pseudomonas aeruginosa and Escherichia coli each accounted for 14.7%.
Results
Phenotypic carbapenem resistance was high, and most isolates produced carbapenemases.
Resistance to meropenem was 77.3% and to imipenem 75.3%, determined by MIC testing.
Carbapenemase production was detected in 84.0% of isolates.
Results
blaKPC and blaNDM were the most prevalent carbapenemase genes and were significantly associated with phenotypic carbapenemase production.
blaKPC prevalence was 28.0% and blaNDM 24.0%, detected by multiplex qPCR (panel: blaKPC, blaNDM, blaOXA-48, blaVIM, blaIMP).
Association with phenotypic carbapenemase production: P = 0.002 for blaKPC and P = 0.006 for blaNDM.
Results
Carbapenemase-producing isolates were associated with worse glycemic control than non-producers.
Carbapenemase producers had significantly higher fasting glucose and HbA1c levels than non-producers (P < 0.001).
The authors conclude poor glycemic control was strongly associated with these resistant infections.
Results
Carbapenemase production was not significantly associated with Wagner grade.
The association with Wagner grade had P = 0.570.
Conclusions
The authors conclude that glycemic control is a modifiable driver of antimicrobial resistance in DFUs and call for integrated management.
They emphasize integrated metabolic management, molecular surveillance, and antimicrobial stewardship.
The study is cross-sectional, so associations do not establish causality.
What This Means
This study looked at 150 people with infected diabetic foot ulcers and tested the bacteria in their deep tissue samples for resistance to carbapenems, a class of powerful last-resort antibiotics. Most infections involved Klebsiella pneumoniae, and about three-quarters of the bacteria were resistant to meropenem and imipenem. Over 80% of the isolates produced carbapenemase enzymes, which break down these drugs. Genetic testing showed that the genes blaKPC and blaNDM were the most common ones behind this resistance.
People whose infections involved carbapenemase-producing bacteria had significantly higher fasting blood glucose and HbA1c (a measure of long-term blood sugar) than those whose infections did not. The severity of the ulcer, measured by Wagner grade, was not significantly linked to carbapenemase production.
This research suggests that poor blood sugar control may be tied to drug-resistant infections in diabetic foot ulcers, and that managing diabetes, tracking resistance genes, and careful antibiotic use may all matter. Because this was a single cross-sectional study, it shows an association and cannot prove that high blood sugar causes resistant infections.
Othman G, A Badawy A, Hamed Al-Serwi R, El Sayed Zaki M, Tharwat Abou El-Khier N, Alkassaby N, et al.. (2026). Molecular epidemiology of carbapenemase-producing gram-negative bacilli in diabetic foot infections: association with glycemic control.. Frontiers in cellular and infection microbiology. https://doi.org/10.3389/fcimb.2026.1847743